The presence of hyperinsulinemia together with increased tumor proliferation and glucose uptake observed in obese rodents, was reduced with therapies with insulin-lowering effects, such as an SGLT2 inhibitor or a liver-specific mitochondrial uncoupler of oxidative phosphorylation. Here, INS is linked to hyperinsulinism.